Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus.
Long-term safety profile of belimumab plus standard therapy in patients with systemic lupus erythematosus. Arthritis Rheum. 2012 Oct; 64(10):3364-73.